NASDAQ:AKAN Akanda (AKAN) Stock Price, News & Analysis $1.26 -0.05 (-3.82%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$1.04 -0.22 (-17.54%) As of 08/22/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock About Akanda Stock (NASDAQ:AKAN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Akanda alerts:Sign Up Key Stats Today's Range$1.25▼$1.3450-Day Range$1.05▼$1.4552-Week Range$0.93▼$2.82Volume4.28 million shsAverage Volume559,038 shsMarket Capitalization$1.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom. Read More Akanda Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks22nd Percentile Overall ScoreAKAN MarketRank™: Akanda scored higher than 22% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Akanda. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioAkanda has a P/B Ratio of 0.42. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.11% of the float of Akanda has been sold short.Short Interest Ratio / Days to CoverAkanda has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Akanda has recently increased by 48.24%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAkanda does not currently pay a dividend.Dividend GrowthAkanda does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.11% of the float of Akanda has been sold short.Short Interest Ratio / Days to CoverAkanda has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Akanda has recently increased by 48.24%, indicating that investor sentiment is decreasing significantly. News and Social Media3.0 / 5News Sentiment0.35 News SentimentAkanda has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Akanda this week, compared to 0 articles on an average week.Search Interest1 people have searched for AKAN on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Akanda to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Akanda insiders have not sold or bought any company stock.Percentage Held by Insiders20.39% of the stock of Akanda is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 1.00% of the stock of Akanda is held by institutions.Read more about Akanda's insider trading history. Receive AKAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akanda and its competitors with MarketBeat's FREE daily newsletter. Email Address AKAN Stock News HeadlinesAkanda announces reverse stock splitAugust 22 at 11:04 PM | msn.comAkanda Corp. Completes Acquisition of First Towers & Fiber Corp.August 22 at 4:50 PM | tipranks.comAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation. | Paradigm Press (Ad)Akanda Corp. Announces Reverse Stock Split Effective August 26, 2025August 22 at 10:10 AM | tipranks.comWrit petition filed seeking judicial commission to probe Sohag murderJuly 13, 2025 | msn.comAkanda Corp. (AKAN) Latest Stock News & Headlines - Yahoo FinanceJuly 8, 2025 | finance.yahoo.comBangladesh court sentences fugitive Ex-PM Hasina to six months for contemptJuly 3, 2025 | msn.comIndia Tightens Border Trade With Bangladesh, Restricts Some Fabric Shipments to Ocean RoutesJuly 3, 2025 | yahoo.comSee More Headlines AKAN Stock Analysis - Frequently Asked Questions How have AKAN shares performed this year? Akanda's stock was trading at $1.60 at the beginning of the year. Since then, AKAN shares have decreased by 21.3% and is now trading at $1.26. When did Akanda's stock split? Akanda shares reverse split on Thursday, May 23rd 2024.The 1-40 reverse split was announced on Thursday, May 23rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, May 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. When did Akanda IPO? Akanda (AKAN) raised $16 million in an IPO on Tuesday, March 15th 2022. The company issued 4,000,000 shares at $4.00 per share. How do I buy shares of Akanda? Shares of AKAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Akanda own? Based on aggregate information from My MarketBeat watchlists, some other companies that Akanda investors own include Pacific Biosciences of California (PACB), Tilray Brands (TLRY), Recursion Pharmaceuticals (RXRX), Editas Medicine (EDIT), SoundHound AI (SOUN), Mobile-health Network Solutions (MNDR) and Ginkgo Bioworks (DNA). Company Calendar Today8/24/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:AKAN CIK1888014 Webwww.akandacorp.com Phone44-20-3488-9514FaxN/AEmployees110Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.39 Quick Ratio1.39 Sales & Book Value Annual Sales$840 thousand Price / Sales2.15 Cash FlowN/A Price / Cash FlowN/A Book Value$3.00 per share Price / Book0.42Miscellaneous Outstanding Shares1,430,000Free Float1,136,000Market Cap$1.80 million OptionableNot Optionable Beta1.59 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:AKAN) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akanda Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akanda With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.